APA (7th ed.) Citation

M, P., & DM, M. (2011). Benefits and costs of rapid drug susceptibility in Staphylococcus aureus bacteremia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52(8), 1079. https://doi.org/10.1093/cid/cir088

Chicago Style (17th ed.) Citation

M, Parta, and Musher DM. "Benefits and Costs of Rapid Drug Susceptibility in Staphylococcus Aureus Bacteremia." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 52, no. 8 (2011): 1079. https://doi.org/10.1093/cid/cir088.

MLA (9th ed.) Citation

M, Parta, and Musher DM. "Benefits and Costs of Rapid Drug Susceptibility in Staphylococcus Aureus Bacteremia." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 52, no. 8, 2011, p. 1079, https://doi.org/10.1093/cid/cir088.